CLL Care Webinar “ASH 2024 CLL Highlights” (Speaker: Antonio Cuneo)
  • Highlight the latest advancements in frontline CLL therapies, including BTKi and BCL2i combinations and fixed-duration treatments
  • Explore the role of MRD-guided treatment strategies in CLL, focusing on early response indicators and treatment adjustments
  • Discuss the significance of predictive markers in CLL prognosis and explore emerging therapies for relapsed/refractory CLL, along with the future direction of treatment
×

Thank you! Your message has been sent.

    Get Case Study

    Improving the treatment care of patients with Multiple Myeloma through regular digital connection between International, National Experts and haematologists in Europe

      Get Brochure